A new method to quantify the effect of co-medication on the efficacy of abiraterone in metastatic castration-resistant prostate cancer patients

• Glavni autori: Bertalan Fekete (Autor), Lili Bársony (Autor), Krisztina Biró (Autor), Fruzsina Gyergyay (Autor), Lajos Géczi (Autor), Attila Patócs (Autor), Barna Budai (Autor)
• Format: Knjiga
• Izdano: Frontiers Media S.A., 2023-09-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Background and Objective: Patients with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone acetate (AA) have co-morbidities treated with different drugs. The aim was to quantify the potential effect of co-medications on AA treatment duration (TD) and overall survival (O...